Indiatimes Representative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bharat Biotech’s Covaxin Effective Against Brazil Covid-19 Variant, Finds Study Indiatimes 2 hours ago © Provided by Indiatimes Bharat Biotech s ‘Covaxin’ neutralises the Brazilian variant of SARS-CoV-2, the novel coronavirus behind the Covid-19 pandemic, scientists at Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV) said in a new study. © Provided by Indiatimes Reuters The findings come a couple of weeks after the ICMR announced that indigenously-developed Covid-19 vaccine is effective against the UK variant (B.1.1.7) as well as the Indian (double mutant) variant B.1.617 the latter is yet to be designated a “variant of concern” status. A variant of interest (VOI) can become a variant of concern (VOC) a higher threat if it has demonstrated increased transmissibility, increased virulence, a change in clinical disease, or decreased effectiveness of efforts to control or treat the Covid-19 disease.

South africaAndhra pradeshUnited kingdomSouth africanSujeet kumar singhNational institute of virologyIndian council of medical researchNational centre for diseaseBharat biotechIndian councilMedical researchNational instituteIndiatimes reutersAfter beingNational centreDisease control